[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"basivertebral-nerve-ablation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:basivertebral-nerve-ablation":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100635992","monopolar-basivertebral-nerve-ablation-for-axial-low-back-pain-100635992",false,"NCT07559890","Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain","Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain - Single-Arm Proof-of-Concept Study","Inclusion Criteria:\n\n* Axial low back pain (with or without lateral component).\n* Presence of Modic type I or II changes at ≥ 1 level.\n* Age over 18 years.\n* Duration of pain ≥ 6 months.\n* Completion of full conservative management for ≥ 3 months.\n\nExclusion Criteria:\n\n* Coagulation disorders.\n* Platelet abnormalities.\n* Lack of informed consent.\n* Generalized solid tumor.\n* Hematopoietic malignancy.\n* Radicular pain.\n* Alternative primary pain generators other than axial low back pain.\n* Previous spinal surgery.\n* Targeted level located above L3\u002FL4\n* Osteoporosis","ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23],"NA","Determination of efficacy and safety of Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain treatment, including the method optimization.",[26,27],"Chronic Back Pain","Basivertebral Nerve Ablation",[29,30,31],"chronic back pain","basivertebral nerve ablation","radiofrequency","RECRUITING","2026-06-04",{"date":35,"type":36},"2026-06-05","ACTUAL",{"date":38,"type":36},"2026-05-04",{"date":40,"type":20},"2029-05",{"name":42,"class":43},"EPC Education s.r.o.","OTHER",3,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":54,"phases":4,"briefSummary":55,"conditions":56,"keywords":59,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":44},"100626284","time-to-bbvna-relief-100626284","NCT07433634","Time to BBVNA Relief","Temporal Trends and Predictors of Clinical Response Following Basivertebral Nerve (BVN) Ablation: A Prospective Observational Cohort Study","Inclusion Criteria:\n\n* Diagnosis of chronic axial low back pain with vertebrogenic features\n* Scheduled for BVN ablation\n* Able to provide informed consent\n* Capable of participating in weekly virtual\u002Ftelephone follow-up for 8 weeks and in- person or remote follow-up at 3 and 6 months through 2 years\n\nExclusion Criteria:\n\n* Prior spinal neuromodulation therapy (e.g., spinal cord stimulation or intrathecal pump) within the past 6 months\n* Active substance use disorder or uncontrolled psychiatric illness that may interfere with participation\n* Cognitive impairment limiting ability to complete surveys or provide informed consent\n* Pregnancy\n* Incarceration or current status as a prisoner",{"count":53,"type":20},200,"OBSERVATIONAL","Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors of clinical response. This study aims to evaluate clinical outcomes longitudinally following BVNA and identify baseline predictors of response.",[57,58,27],"Low Back Pain","Vertebrogenic Pain Syndrome",[60,61,62,63,64,65],"Pain relief trajectory","Basivertebral nerve ablation","Vertebrogenic low back pain,","Responder phenotypes","Clinical Outcomes","Radiofrequency Ablation","2026-02-27",{"date":68,"type":36},"2026-03-03",{"date":70,"type":36},"2024-04-19",{"date":72,"type":20},"2026-10",{"name":74,"class":43},"Yale University"]